Chronic Administration of Gelesis100 to Non-Diabetic Overweight and Obese Subjects Significantly Decreases Fasting Glucose and Normalizes Fasting Glucose Status in Prediabetic Subjects Through Both Weight-Dependent and Weight-Independent Mechanisms

Abstract

Abstract is not available.